Bioland Pharmaceutical Ltd.

Bioland Pharma is an innovative pharmaceutical enterprise integrating R&D, production, and sales. We specialize in the development and production of innovative and generic APIs, including high-potency APIs (OEB4 and OEB5), anti-tumor APIs, cardiovascular and cerebrovascular APIs, as well as pediatric APIs. There are two production sites in our group, both of which have passed audits or on-site inspections by US FDA, EDQM, and China NMPA. Several products have been successfully registered in domestic and international markets. Key APIs: Clindamycin Palmitate HCl, Fludarabine Phosphate, Oseltamivir Phosphate, Phytonadione； Key Excipients: SNAC、Sodium Stearyl Fumarate